Compare PDX & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDX | QDEL |
|---|---|---|
| Founded | 2019 | 1979 |
| Country | NY | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.1M | 1.0B |
| IPO Year | N/A | 2022 |
| Metric | PDX | QDEL |
|---|---|---|
| Price | $21.32 | $14.12 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 77.9K | ★ 1.9M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 4.95% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.47 | $9.92 |
| 52 Week High | $25.25 | $35.58 |
| Indicator | PDX | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 46.40 | 56.94 |
| Support Level | $21.11 | $10.39 |
| Resistance Level | $21.48 | $17.78 |
| Average True Range (ATR) | 0.29 | 1.01 |
| MACD | -0.04 | 0.43 |
| Stochastic Oscillator | 7.46 | 66.51 |
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.